ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
0,90
0,00
(0,00%)
Geschlossen 23 Juni 5:30PM

Genincode Plc (GENI) Aktie

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
0,90
( - )
Gebot
0,85
Fragen
0,95
Volumen
19.167
0,90 Tagesbereich 0,905
0,825 52-Wochen-Bereich 5,25
Marktkapitalisierung
Handelsende
0,90
Handelsbeginn
0,90
Letzte Trade
1316
@
0.95
(O)
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
6.871.231p
Ausgegebene Aktien
753.041.137
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-0,43
Gewinn pro Aktie (EPS)
-0,02
Erlöse (LTM)
3,08M
Nettogewinn (LTM)
-5,71M

Über Genincode Plc

GENinCode Plc engages in the development and commercialization of clinical genetic tests for predictive analysis of risk to a patient’s health based on genes in the United Kingdom, Spain, Italy, the United States, Germany, and internationally. The company offers CARDIO inCode Score, a genetic test t... GENinCode Plc engages in the development and commercialization of clinical genetic tests for predictive analysis of risk to a patient’s health based on genes in the United Kingdom, Spain, Italy, the United States, Germany, and internationally. The company offers CARDIO inCode Score, a genetic test to evaluate the risk of coronary heart disease; LIPID inCode, a genetic test for the diagnosis of familial hypercholesterolemia with further coronary risk stratification of the patient; and SUDD inCode, a genetic diagnostic test for familial heart diseases, such as cardiomyopathies, channelopathies, and aortopathies related with sudden cardiac death syndrome. It also provides THROMBO inCode, a genetic test for the diagnosis of hereditary thrombophilia and for assessing the patient's risk of thrombosis; THROMBO inCode reproductive health, a genetic test that evaluates the impact of hereditary thrombophilia in patients with repeated miscarriages; and risk of ovarian cancer algorithm test product. In addition, the company is involved in Medical and scientific research activities. GENinCode Plc was incorporated in 2018 and is based in Manchester, the United Kingdom. Mehr anzeigen

Sektor
Healthcare
Branche
Medical Diagnostics & Screening
Hauptsitz
Manchester, United Kingdom
Gegründet
2026
Genincode Plc is listed in the Healthcare sector of the Londoner Börse with ticker GENI. The last closing price for Genincode was 0,90p. Over the last year, Genincode shares have traded in a share price range of 0,825p to 5,25p.

Genincode currently has 753.041.137 shares in issue. The market capitalisation of Genincode is £6,78 million. Genincode has a price to earnings ratio (PE ratio) of -0.43.

GENI Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.05-5.263157894740.950.9510.82564235050.90227746DE
4-0.175-16.27906976741.0751.3750.82579569661.05815851DE
12-0.175-16.27906976741.0751.3750.82570958061.11660286DE
26-1.7-65.38461538462.62.650.82557062141.14545062DE
52-1.35-602.255.250.82532242731.44641892DE
156-11.1-92.51213.50.82512539081.91935657DE
260-47.6-98.144329896948.548.50.8258088912.91810648DE

GENI - Frequently Asked Questions (FAQ)

What is the current Genincode Plc share price?
The current share price of Genincode Plc is 0,90p
How many Genincode Plc shares are in issue?
Genincode Plc has 753.041.137 shares in issue
What is the market cap of Genincode Plc?
The market capitalisation of Genincode Plc is GBP 6,78M
What is the 1 year trading range for Genincode Plc share price?
Genincode Plc has traded in the range of 0,825p to 5,25p during the past year
What is the PE ratio of Genincode Plc?
The price to earnings ratio of Genincode Plc is -0,43
What is the cash to sales ratio of Genincode Plc?
The cash to sales ratio of Genincode Plc is 2,2
What is the registered address of Genincode Plc?
The registered address for Genincode Plc is One St. Peters Square, Manchester, M2 3DE
What is the Genincode Plc website address?
The website address for Genincode Plc is www.genincode.com
Which industry sector does Genincode Plc operate in?
Genincode Plc operates in the Medical Diagnostics & Screening sector

GENI Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen